Current concepts in cryptococcosis

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
T F Patterson, V T Andriole

Abstract

Cryptococcus neoformans has become an increasingly important pathogen. Cryptococcosis is an important cause of morbidity and mortality in immunocompromised hosts and is the second most common fungal infection complicating AIDS. In recent years, research has focused on the host defenses against Cryptococcus and has led to an improved understanding of the capsular virulence of the organism, the mechanisms of T-cell defenses, and the role of phagocytic cells in the fungistasis and killing of cryptocci. Amphotericin B with or without flucytosine has clearly improved treatment of cryptococcosis, but therapy is associated with significant toxicity. Current investigation is focused on the triazoles, which may offer improved therapy for cryptococcosis. In this report, we review recent developments in the understanding of the host defenses against Cryptococcocus and discuss current recommendations for the management of cryptococcosis.

References

Jul 1, 1978·The Journal of Experimental Medicine·R B JohnstonZ A Cohn
Jun 1, 1977·American Journal of Epidemiology·J E BennettD H Howard
Nov 1, 1978·Journal of Clinical Microbiology·E Prevost, R Newell
Sep 1, 1979·Journal of Clinical Microbiology·B L Zimmer, G D Roberts
Jul 19, 1979·The New England Journal of Medicine·J E BennettD W Alling
Nov 29, 1976·JAMA : the Journal of the American Medical Association·M P Berger, J Paz
Feb 1, 1977·Antimicrobial Agents and Chemotherapy·C A Kauffman, P T Frame
Aug 1, 1977·The British Journal of Dermatology·A KamalamA S Thambiah
Jun 1, 1975·The Journal of Allergy and Clinical Immunology·S C Schimpff, J E Bennett
Oct 1, 1975·The Journal of Infectious Diseases·J P UtzS Shadomy
Oct 1, 1985·The Journal of Clinical Investigation·T GanzR I Lehrer
Aug 1, 1986·The Journal of Antimicrobial Chemotherapy·E Palou de FernandezM H Tarbit
Jan 1, 1987·Annals of Internal Medicine·M A VivianiM Almaviva
Aug 1, 1987·The Journal of Infectious Diseases·J R PerfectD T Durack
Apr 1, 1988·The Journal of Clinical Investigation·D L GrangerD T Durack
Jul 1, 1987·The Journal of Infectious Diseases·E J BottoneG P Wormser
Aug 6, 1987·The New England Journal of Medicine·W E DismukesUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Oct 1, 1987·Chest·L Wasser, W Talavera
Apr 1, 1987·Southern Medical Journal·J L GluckL M Pass
Oct 1, 1987·Oral Surgery, Oral Medicine, and Oral Pathology·M GlickM S Greenberg
Jan 1, 1986·Movement Disorders : Official Journal of the Movement Disorder Society·C G GoetzD C Garron
Mar 1, 1986·The Journal of Infectious Diseases·M G RinaldiW K Hadley
Aug 1, 1986·European Journal of Clinical Microbiology·V Hopwood, D W Warnock
Dec 1, 1986·The Journal of Infectious Diseases·R Y ShimizuM N Clancy
Feb 1, 1987·Diagnostic Microbiology and Infectious Disease·H J ShadomyR Y Chau
Feb 1, 1987·Journal of Clinical Microbiology·D H Ellis
Jan 1, 1987·Journal of the American Academy of Dermatology·F GranierJ Thivolet
Jul 1, 1986·The American Journal of Medicine·B PolskyD Armstrong
Jun 1, 1985·European Journal of Cancer & Clinical Oncology·P M MannucciN Cascinelli

❮ Previous
Next ❯

Citations

May 20, 1998·Annals of Epidemiology·A Casadevall
Jan 1, 1992·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·G J Merkel, R K Cunningham
Jan 1, 1992·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·T G MitchellJ W Taylor
Jan 1, 1993·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·G J Merkel, B A Scofield
Jan 1, 1994·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·G J Merkel, B A Scofield
Oct 12, 2002·Immunopharmacology and Immunotoxicology·Abbas MirshafieyMasoumeh Hadjavi
Dec 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·D N BurnsF M Gordin
Sep 1, 1992·Journal of Clinical Pathology·F R Knight
Oct 8, 1998·American Journal of Respiratory Cell and Molecular Biology·A A IzzoM F Lipscomb
Dec 9, 2010·International Journal of STD & AIDS·T Warkentien, N F Crum-Cianflone
Nov 26, 2008·Leukemia & Lymphoma·Martin Schmidt-HieberEckhard Thiel
Oct 3, 2009·Epidemiology and Infection·Y-M ChuangP R Hsueh
Jul 30, 2003·Animal Health Research Reviews·David J Speare
Jul 1, 1996·American Journal of Reproductive Immunology : AJRI·S Z BadawyS Khan
Jun 1, 2013·Balsaeng'gwa saengsig·Chung-Hoon KimByung-Moon Kang
May 1, 1994·Annals of Saudi Medicine·G F ArajM M Uwaydah
Feb 7, 1998·FEMS Immunology and Medical Microbiology·G J Merkel, B A Scofield
Feb 1, 2014·Infection·L Hunter-EllulM G Wilkerson
May 1, 1992·Journal of Clinical Microbiology·E D Spitzer, S G Spitzer
Mar 1, 1997·Journal of Clinical Microbiology·C Lo PassoA Pernice

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.